INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 430m ago
House PTR30m ago
SEC 13F29m ago
Robinhood Chain29m ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,704 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
6
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Grant or award
A—
45.1K sh
Jun 11, 2026Jun 15, 2026
Page 669 of 1718
← PrevNext →
traded Jun 11, 2026
+4d
SEC Form 4

Evidence

5
HE
Hughes Edmond E. Jr.Ex VP & Chief HR Officer
HIIHUNTINGTON INGALLS INDUSTRIES, INC.
Grant or award
A—
10 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

5
WM
Wilkinson Amy MarieDirector
HUTHut 8 Corp.
Grant or award
A—
4,550 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
CD
Chewning Eric D.EVP, Maritime Sys & Corp STR
HIIHUNTINGTON INGALLS INDUSTRIES, INC.
Grant or award
A—
10 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

5
RR
Rickertsen RickDirector
HUTHut 8 Corp.
Option exercise
M—
14.8K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
WM
Wilkinson Amy MarieDirector
HUTHut 8 Corp.
Option exercise
M—
15.7K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
SV
Semah VictorChief Legal Officer
HUTHut 8 Corp.
Grant or award
A—
27.2K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
CC
Cowan ChadChief Scientific Officer
IPSCCentury Therapeutics, Inc.
Tax withholding
F$802
358 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
JM
Jansen John MDirector
OKLOOklo Inc.
Grant or award
A—
3,213 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
GJ
Glennan Sean JosephChief Financial Officer
HUTHut 8 Corp.
Grant or award
A—
27.2K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
RR
Rickertsen RickDirector
HUTHut 8 Corp.
Option exercise
M—
14.8K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
RR
Rickertsen RickDirector
HUTHut 8 Corp.
Grant or award
A—
4,372 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
NW
Newton Charles W.Director
KROSKeros Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$5,522
550 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
WL
Wang LaiPresident, Global Head of R&D
ONCBeOne Medicines Ltd.
Grant or award
A—
229.8K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$31K
13.8K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

2
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Grant or award
A—
87.3K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

0
CM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$41K
500 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

0
RA
Rohrstock AriehPresident, Gilat Peru
GILTGILAT SATELLITE NETWORKS LTD
Option exercise · 10b5-1 plan
M—
30.0K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

0
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Derivative conversion · 10b5-1 plan
C—
57.9K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

0
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Derivative conversion · 10b5-1 plan
C—
57.9K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

57
GD
Gray Steven DDirector
INRINFINITY NATURAL RESOURCES, INC.
Open-market purchase
BUY$320K
25.0K sh
Jun 12, 2026Jun 12, 2026
traded Jun 12, 2026
+0dSEC Form 4

Evidence

54
RA
Ross AndrewPortfolio Manager
ACLOXAristotle Pacific Enhanced CLO Income Fund
Open-market purchase
BUY$150K
5,871 sh
May 14, 2026Jun 12, 2026
traded May 14, 2026
+29dSEC Form 4

Evidence

53
SA
Still AshleyDirector
DASHDoorDash, Inc.
Open-market sale
SELL$179K
1,164 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

51
MB
Meadows BenjaminChief Commercial Officer
QTRXQuanterix Corp
Open-market purchase
BUY$9,695
3,500 sh
May 12, 2026Jun 12, 2026
traded May 12, 2026
+31dSEC Form 4

Evidence

42
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$857K
3,405 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

41
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$1.13M
4,500 sh
Jun 11, 2026Jun 12, 2026
traded Jun 11, 2026
+1dSEC Form 4

Evidence

39
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$125K
500 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

39
KN
Karellis NikolaosDirector
SBLKStar Bulk Carriers Corp.
Open-market sale
SELL$539K
20.0K sh
Jun 11, 2026Jun 12, 2026
traded Jun 11, 2026
+1dSEC Form 4

Evidence

37
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market sale
SELL$652K
5,000 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

36
PP
Pittas Aristeidis PDirector
ESEAEUROSEAS LTD.
Open-market purchase
BUY$17K
250 sh
Jun 11, 2026Jun 12, 2026
traded Jun 11, 2026
+1dSEC Form 4

Evidence

36
FM
Fruhbeis Todd MichaelDirector
STRRStar Equity Holdings, Inc.
Open-market purchase
BUY$2,943
300 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

36
PP
Pittas Aristeidis PDirector
ESEAEUROSEAS LTD.
Open-market purchase
BUY$17K
250 sh
Jun 11, 2026Jun 12, 2026
traded Jun 11, 2026
+1dSEC Form 4

Evidence

35
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$64K
257 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

35
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$58K
232 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

35
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$174K
697 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

33
WM
Wong-Zaza MelvinaDirector
KRNYKearny Financial Corp.
Open-market purchase
BUY$30K
3,500 sh
Jun 11, 2026Jun 12, 2026
traded Jun 11, 2026
+1dSEC Form 4

Evidence

33
PS
Pombier SamanthaVice President and Controller
PHINPHINIA INC.
Open-market sale
SELL$183K
2,227 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

32
HW
Harkins William Wayne IIPrincipal Accounting Officer
ROLROLLINS INC
Grant or award
A—
6,112 sh
Feb 20, 2026Jun 12, 2026
traded Feb 20, 2026
+112dSEC Form 4

Evidence

31
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market purchase
BUY$5.38M
280.2K sh
Jun 11, 2026Jun 12, 2026
traded Jun 11, 2026
+1dSEC Form 4

Evidence

30
SC
Schwarzkopf CynthiaDirector
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$814K
19.5K sh
Jun 11, 2026Jun 12, 2026
traded Jun 11, 2026
+1dSEC Form 4

Evidence